Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
批准号:
10444613
负责人:
ROBERT N WEINREB
金额:
$69.56万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-05-01 至 2025-04-30
关键词:
3-DimensionalAgeAngiographyAreaArtificial IntelligenceAwardBlindnessBlood VesselsBlood capillariesCaringClassificationClinicalClinical TrialsComplexDataData SetDetectionDevelopmentDiagnosisDiseaseDisease ProgressionDropoutEvaluationEyeEye diseasesFunctional disorderFundingGlaucomaGlobal ChangeImageIndividualInstitutesInstitutional Review BoardsKnowledgeLaboratoriesLeadLongitudinal StudiesMachine LearningMeasurableMeasurementMeasuresMonitorMultimodal ImagingOpen-Angle GlaucomaOptic DiskOptical Coherence TomographyPatientsPublicationsQuality of lifeResearchRetinaRiskRisk EstimateRisk ReductionScienceScotomaSeverity of illnessSpecificitySuspect GlaucomasTestingThickTimeTissuesVisionVisual Fieldsage relatedbaseclinical careclinical imagingcohortcostdeep learningdensitydiagnostic accuracyeffective therapyganglion cellimaging modalityimprovedinstrumentmaculamultimodalitynovelnovel therapeuticspredictive modelingpreventracial diversityrate of changeretina blood vessel structureretinal nerve fiber layerstatistical learning
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Optical coherence tomography angiography (OCTA) is a non-invasive, 3-dimensional imaging method to
visualize and quantify microvasculature throughout the retina. The proposed study evaluates the clinical utility
of OCTA measurements compared to standard structural measurements of the optic nerve head (ONH), retinal
nerve fiber layer (RNFL) and macula measured using the current clinical imaging standard, spectral domain
optical coherence tomography (OCT) to predict and detect progression of disease in glaucoma suspects and
glaucoma patients. Our research, and that of others, has shown that superficial retinal vessel density
(proportion of measured area composed of blood vessels) in the ONH region and macula is less dense in open
angle glaucoma (OAG) eyes than in healthy eyes. Moreover, diagnostic accuracy is improved with increasing
disease severity. Research from our laboratory suggests that the diagnostic accuracy of vessel density is
similar to that of OCT-measured RNFL thickness, and that vessel density is reduced in retinal regions
associated with localized visual field (VF) defects. These cross-sectional results strongly suggest that OCTA
measurements reflect damage to tissues relevant to the pathophysiology of OAG. In a longitudinal study, the
mean rate of change in macula vessel density was shown to be significantly faster in OAG eyes than in
glaucoma suspect or healthy eyes. Finally, recent results indicate that shallow machine learning analyses of
combinations of OCTA measurements can improve classification of healthy and glaucoma eyes compared to
standard instrument measurements as can deep learning analyses of OCTA enface images. The current study
provides a unique opportunity to extend the longitudinal OCTA data that has already been collected from 480
eyes racially diverse individuals for up to 10 years to investigate vessel density change over time in healthy,
glaucoma suspect and OAG eyes, and to compare it to other imaging modalities. The aims of this study are 1)
to improve our understandingof the relative change over time of OCTA and OCT measurements in healthy and
diseased eyes to identify true disease-related change more accurately and 2) to improve our understanding of
the risk of developing glaucomatous progression using statistical and deep learning-based analyses of multi-
modal OCTA and OCT measurements. The proposed studies will enhance our understanding of age and
glaucoma-related change in vessel density and retinal tissue thickness allowing us to predict and detect
change more accurately, thus possibly slowing the rate of progression and consequently reducing the risk of
reduction of vision related quality of life, including blindness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
-
批准号:10615796
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2018
-
负责人:ROBERT N WEINREB
-
依托单位:
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
-
批准号:9921397
-
项目类别:
-
资助金额:$50.37万
-
财政年份:2018
-
负责人:ROBERT N WEINREB
-
依托单位:
Ophthalmology and Visual Sciences Career Development K12 Program
-
批准号:8847895
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2015
-
负责人:ROBERT N WEINREB
-
依托单位:
Ophthalmology and Visual Sciences Career Development K12 Program
-
批准号:9254555
-
项目类别:
-
资助金额:$64.02万
-
财政年份:2015
-
负责人:ROBERT N WEINREB
-
依托单位:
Ophthalmology and Visual Sciences Career Development K12 Program
-
批准号:10450760
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2015
-
负责人:ROBERT N WEINREB
-
依托单位:
Ophthalmology and Visual Sciences Career Development K12 Program
-
批准号:9040968
-
项目类别:
-
资助金额:$43.98万
-
财政年份:2015
-
负责人:ROBERT N WEINREB
-
依托单位:
Ophthalmology and Visual Sciences Career Development K12 Program
-
批准号:10190539
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2015
-
负责人:ROBERT N WEINREB
-
依托单位:
Ophthalmology and Visual Sciences Career Development K12 Program
-
批准号:10676982
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2015
-
负责人:ROBERT N WEINREB
-
依托单位:
Sirtuins in Glaucomatous Optic Neuropathy
-
批准号:8389546
-
项目类别:
-
资助金额:$59.6万
-
财政年份:2011
-
负责人:ROBERT N WEINREB
-
依托单位:
Sirtuins in Glaucomatous Optic Neuropathy
-
批准号:8041809
-
项目类别:
-
资助金额:$59.58万
-
财政年份:2011
-
负责人:ROBERT N WEINREB
-
依托单位:
Sirtuins in Glaucomatous Optic Neuropathy
-
批准号:8204632
-
项目类别:
-
资助金额:$63.96万
-
财政年份:2011
-
负责人:ROBERT N WEINREB
-
依托单位:
EICOSANOIDS IN OUTFLOW PATHWAY OF EYE: GLAUCOMA
-
批准号:6247542
-
项目类别:
-
资助金额:$4.54万
-
财政年份:1997
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:2444380
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:2165454
-
项目类别:
-
资助金额:$27.68万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:6384654
-
项目类别:
-
资助金额:$34.73万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:6804123
-
项目类别:
-
资助金额:$37.93万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:2165455
-
项目类别:
-
资助金额:$27.51万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
Quantitative Analysis of Optic Disc/Ocular Hypertension
-
批准号:7122359
-
项目类别:
-
资助金额:$38.63万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:2711149
-
项目类别:
-
资助金额:$20.98万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION
-
批准号:6518539
-
项目类别:
-
资助金额:$35.77万
-
财政年份:1995
-
负责人:ROBERT N WEINREB
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: